Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 21.21
+0.12 (0.57%)
Oct 23, 2026, 1:54 PM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 10.97 billion as of October 22, 2026. It is the 7,736th most valuable company in the world and the 1,492nd biggest in China. Its market cap has increased by 23.52% in one year.
Market Cap
10.97B
Enterprise Value
9.12B
Revenue
1.47B
Global Rank
Country Rank
#1,492 China
PE Ratio
n/a
ChartMarket Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 10.97B, a decrease of -67.88%. That is a compound annual growth rate of -20.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 10.97B | 37.71% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BrightGene Bio-Medical Technology | 13.80B |
| Sino Biological,Inc. | 13.73B |
| Jinyu Bio-technology | 13.60B |
| Anhui Anke Biotechnology (Group) | 13.39B |
| GemPharmatech | 12.38B |
| Hualan Biological Vaccine | 11.26B |
| Shanghai Medicilon | 11.03B |
| Chengdu Olymvax Biopharmaceuticals | 10.96B |